4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-16-115794
Chief Executive Officer sold 1,300 shares at an average $20.12 ($26,159)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-25 | Sale : show line 1 in the form | −1,200 | $20.12 | $24,144 | 363,611 | I |
| 2016-04-26 | Sale : show line 2 in the form | −100 | $20.15 | $2,015 | 363,511 | I |
| Open-market sales · 1,300 sh · avg $20.12 · $26,159 | ||||||
Loading xslF345X03/doc4.xml…